BROMOCRIPTINE IN PARKINSONISM - LONG-TERM TREATMENT, DOSE-RESPONSE, AND COMPARISON WITH LEVODOPA

被引:95
作者
PARKES, JD
DEBONO, AG
MARSDEN, CD
机构
[1] UNIV LONDON,DEPT NEUROL,LONDON,ENGLAND
[2] UNIV LONDON,KINGS COLL HOSP,LONDON SE5 8RX,ENGLAND
[3] INST PSYCHIAT,LONDON,ENGLAND
关键词
D O I
10.1136/jnnp.39.11.1101
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1101 / 1108
页数:8
相关论文
共 16 条
[1]   BROMOCRIPTINE IN PARKINSONISM [J].
CALNE, DB ;
TEYCHENNE, PF ;
CLAVERIA, LE ;
EASTMAN, R ;
GREENACRE, JK ;
PETRIE, A .
BMJ-BRITISH MEDICAL JOURNAL, 1974, 4 (5942) :442-444
[2]  
CAMMANI F, 1975, J CLIN ENDOCR METAB, V40, P363
[3]   EFFECT OF ERGOT DRUGS ON CENTRAL CATECHOLAMINE NEURONS - EVIDENCE FOR A STIMULATION OF CENTRAL DOPAMINE NEURONS [J].
CORRODI, H ;
FUXE, K ;
HOKFELT, T ;
LIDBRINK, P ;
UNGERSTEDT, U .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (05) :409-412
[4]   EFFECT OF ERGOT DRUGS ON CENTRAL 5-HYDROXYTRYPTAMINE NEURONS - EVIDENCE FOR 5-HYDROXYTRYPTAMINE RELEASE OR 5-HYDROXYTRYPTAMINE RECEPTOR STIMULATION [J].
CORRODI, H ;
FARNEBO, LO ;
FUXE, K ;
HAMBERGER, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1975, 30 (02) :172-181
[5]  
DEBONO AG, IN PRESS
[6]  
FUXE K, 1974, MED BIOL, V52, P121
[7]   STIMULANT PROPERTIES OF BROMOCRIPTINE ON CENTRAL DOPAMINE RECEPTORS IN COMPARISON TO APOMORPHINE, (+)-AMPHETAMINE AND L-DOPA [J].
JOHNSON, AM ;
LOEW, DM ;
VIGOURET, JM .
BRITISH JOURNAL OF PHARMACOLOGY, 1976, 56 (01) :59-68
[8]   ON-OFF EFFECTS IN PATIENTS WITH PARKINSONS-DISEASE ON CHRONIC LEVODOPA THERAPY [J].
MARSDEN, CD ;
PARKES, JD .
LANCET, 1976, 1 (7954) :292-296
[9]   TREATMENT OF PARKINSONS-DISEASE WITH LEVODOPA COMBINED WITH L-ALPHA-METHYLDOPAHYDRAZINE, AN INHIBITOR OF EXTRACEREBRAL DOPA DECARBOXYLASE [J].
MARSDEN, CD ;
BARRY, PE ;
PARKES, JD ;
ZILKHA, KJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1973, 36 (01) :10-14
[10]  
MCNAY JL, 1966, J PHARMACOL EXP THER, V151, P23